This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks Climb as Summers Withdrawal Bolsters Stimulus Outlook; Apple Falls

NEW YORK ( TheStreet) -- U.S. stocks gained Monday as investors bet on an extension of the Federal Reserve's stimulus program and a smooth leadership transition at the central bank as former U.S. Treasury Secretary Larry Summers withdrew his name from consideration as the next Fed chairman.

Summers, President Obama's apparent favorite to succeed Chairman Ben Bernanke, reportedly removed himself from the running following unusually strong political opposition to his candidacy from Democrats, all but assuring the ascension of current vice-chair and low interest-rate advocate Janet Yellen to run the bank beginning in February.

Markets were further bolstered by Chrysler's plan to file documents this week to hold an initial public offering . Respite from Syria anxieties was also seen as a positive as the U.S. and Russia negotiated a proposal to remove or destroy the Middle Eastern nation's chemical weapons by the middle of next year, delaying airstrikes indefinitely.

The S&P 500 gained 0.57% to 1,697.60. The benchmark index began the session up 18.36% year to date. The Dow Jones Industrial Average added 0.77% to 15,494.78. The Nasdaq dropped 0.12% to 3,717.85.

The Nasdaq's decline came after Wall Street punished Apple (AAPL - Get Report) for the fourth of the past five trading sessions, almost a week after investors shrugged at the new iPhone 5C and iPhone 5S. Shares dropped 3.2% to $450.12 Monday as the stock won the inauspicious distinction of the day's worst performer on the S&P 500.

Conversely, Allegheny Technologies (ATI - Get Report) was the biggest gainer on the S&P, jumping 8.1% to $30.95 after the metals producer said it will sell its tungsten materials business to Kennametal (KMT - Get Report) for $605 million. Kennametal increased 0.9% to $46.39.

Bristol-Myers Squibb (BMY - Get Report) tacked on 3.6% to $45.14 after analysts at JPMorgan upgraded the pharmaceutical stock to "overweight" from "neutral," lifting its price target to $52 from $50 due to catalysts including the company's immunotherapy platform.

Ahead of the open, the New York Federal Reserve's Empire State manufacturing index showed a smaller-than-expected increase to 6.29 for September from 8.24 in August; an increase to 9.2 was expected, according to a Thomson Reuters poll of economists. It was the lowest level since May but remained in expansionary territory for the fourth consecutive month.

The Federal Reserve said that industrial production rose by an as expected 0.4% in August after being flat in July and that capacity utilization increased to an as predicted 77.8% from 77.6%.

President Obama on Wednesday marked the 5-year anniversary of Lehman Brothers' bankruptcy by listing the various reforms his administration has implemented since the crash, but reminded Americans that the economy is not where it needs to be.

The benchmark 10-year Treasury was lifting by 2/32, diluting the yield to 2.880%.

-- Written by Andrea Tse and Joe Deaux in New York

>To contact the writer of this article, click here: Andrea Tse.>

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $110.38 0.00%
BMY $62.23 0.00%
ATI $15.50 0.00%
KMT $26.08 0.00%
FB $92.07 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs